UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.DC 20549

_______________

FORM 10-Q

_______________

FORM 10-Q

☑QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 20162019

OR

☐TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934

For the transition period from:from _______ to _______

Commission File Numberfile number 000-54730

AIRWAREITEM 9 LABS CORP.

(Exact name of registrant as specified in its charter)

7377 E Doubletree Ranch Rd.,Suite 260

Scottsdale,1709 East Bethany Home Road, Phoenix, AZ 8525885016

(Address of principal executive offices)offices and zip code)

(480) 463-42461-833-867-6337

(Registrant’s telephone number) number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

☑Yes ☑  No ☐ No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☑YesYes ☑ No ☐ No (Not required)

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of "large“large accelerated filer," "accelerated filer"” “accelerated filer”, “smaller reporting company”, and "smaller reporting company"“emerging growth company” in Rule 12b-2

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Large Accelerated Filer☐                           Accelerated Filer ☐

Non-Accelerated Filer☐                              Smaller Reporting Company☑

Indicate by check mark whether the registrant is a shell company (as defined inby Rule 12b-2 of the Exchange Act).

Yes ☐ YesNo ☑ No

As of August 16, 2016, there14, 2019, there were 80,579,41063,514,979 shares of the registrant’sissuer’s common stock, $0.0001 par value common stock issued andper share, outstanding.

AIRWARE LABS CORP.

TABLE OF CONTENTS

Special Note Regarding Forward-Looking StatementsSPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

InformationCertain information included in this Quarterly Report on Form 10-Q and other filings of the Registrant under the Securities Act of 1933, as amended (the “Securities Act”), and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as well as information communicated orally or in writing between the dates of such filings, contains forward-looking statementsor may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”), and Section 21E of the Exchange Act. Forward-looking statements in this Quarterly Report on Form 10-Q, including without limitation, statements related to our plans, strategies, objectives, expectations, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities ExchangeLitigation Reform Act of 1934, as amended (“Exchange Act”). This information may involve known1995. Such statements are subject to certain risks, trends and unknownuncertainties that could cause actual results to differ materially from expected results. Among these risks, trends and uncertainties are the availability of working capital to fund our operations, the competitive market in which we operate, the efficient and uninterrupted operation of our computer and communications systems, our ability to generate a profit and execute our business plan, the retention of key personnel, our ability to protect and defend our intellectual property, the effects of governmental regulation, and other factors which may causerisks identified in the actual results, performance or achievements of Airware Labs Corp. (the “Company”),Registrant’s filings with the Securities and Exchange Commission from time to time.

In some cases, forward-looking statements can be materially different from future results, performance or achievements expressed or impliedidentified by any forward-looking statements. Forward-looking statements, which involve assumptions and describe future plans, strategies and expectations of the Company, are generally identifiable by use of the wordsterminology such as “may,” “will,” “should,” “expect,“could,” “anticipate,“expects,” “estimate,“plans,” “believe,“anticipates,” “intend,“believes,” “estimates,” “predicts,” “potential” or “project”“continue” or the negative of these wordssuch terms or other variations on these words or comparable terminology. These forward-looking statements are based on assumptionsAlthough the Registrant believes that may be incorrect, and there can be no assurance that these projections includedthe expectations reflected in these forward-looking statements will come to pass. Actual results of the Company could differ materially from those expressed or implied by the forward-looking statements as a resultcontained herein are reasonable, the Registrant cannot guarantee future results, levels of various factors. Except as required by applicable laws,activity, performance or achievements. Moreover, neither the Company hasRegistrant, nor any other person, assumes responsibility for the accuracy and completeness of such statements. The Registrant is under no obligationduty to update publicly any of the forward-looking statements for any reason, even if new information becomes available or other events occur incontained herein after the future.

*Please note that throughoutdate of this Quarterly Report and unless otherwise noted, the words "we," "our," "us," the "Company," "AIRW," or “Airware” refers to Airware Labs Corp.on Form 10-Q.

PART I - FINANCIAL INFORMATION

ITEM 9 LABS CORP.

FORM 10-Q

JUNE 30, 2019

INDEX

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements.

The

See accompanying notes are an integral part of theseto the unaudited condensed consolidated financial statements.

The

See accompanying notes are an integral part of theseto the unaudited condensed consolidated financial statements.

The

See accompanying notes are an integral part of theseto the unaudited condensed consolidated financial statements.

See accompanying notes to the unaudited condensed consolidated financial statements.

ITEM 9 LABS CORP.

(FORMERLY AIRWARE LABS CORP. AND SUBSIDIARYCORP)

NOTES TO CONDENSEDCODENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)(Unaudited)

1.Note 1 – Description of Business and Summary of Significant Accounting Policies and Use

Description of EstimatesBusiness

Basis of Presentation and Organization

AirwareItem 9 Labs Corp. (“AirwareItem 9 Labs” or the “Company”), formerly Crown DynamicsAirware Labs Corp., is a Delaware corporation. The Company was incorporated under the laws of the State of Delaware on June 15, 2010.2010 as Crown Dynamics Corp. On October 26, 2012, the Articles of Incorporation were amended to reflect a name change to Airware Labs Corp, and on April 2, 2018, they were amended again to reflect the name change to Item 9 Labs Corp.

On October 18, 2018 the Company effected a 1 for 20 reverse stock split of the Company’s common stock. The par value and number of authorized shares were not adjusted as a result of the reverse stock split. The total number of shares outstanding at the time of the split was adjusted from 1,095,332,835 to 54,766,642. All share information in these financial statements has been retroactively adjusted to reflect the effect of the reverse split.

On March 20, 2012, through an equity exchange agreement,2018, the Company acquiredclosed on an Agreement and Plan of Exchange (the “Agreement”) to acquire all of the membership interests of BSSD Group, LLC (“BSSD”), an Arizona limited liability company formed on May 2, 2017, in exchange for newly issued restricted shares of the Company’s common stock (the “Shares”), which represent approximately 75% of the issued and outstanding stock of Airware Holdings, Inc., a Nevada corporation (“Airware”), in exchange for shares of the Company’s newly-issued common stock. Airware Holdings, Inc.stock on a fully-diluted basis. The 40,355,771 Shares were distributed pro-rata to the BSSD members. As part of the Agreement, the Company agreed to increase its authorized shares of common stock to two billion.

For accounting purposes the transaction is being recorded as a reverse recapitalization, with BSSD as the accounting acquirer. Consequently, the historical pre-merger financial statements of BSSD are now those of the Company. In its determination that BSSD was formed in February 2010the accounting acquirer, the Company considered pertinent facts and circumstances, including the following: (i) the BSSD owners received the largest portion of the voting rights of the combined entity; (ii) the management team of the combined entity is a non-prescription medical products company.primarily comprised of owners or management of BSSD; (iii) the continuing business of the combined entity will be the business of BSSD. The principal business purposeaccompanying consolidated financial statements reflect the consolidated operations of the Company is to develop, manufacture and distribute breathing solutions that address major respiratory challenges impacting human health.from March 20, 2018.

Through a licensing agreement, the Company grows medical marijuana and produces cannabis related products at their facility in Pinal County, Arizona on behalf of licensed medical marijuana dispensaries in the state of Arizona. The major assets of the Company, consisting of five acres of land and a cultivation facility, were contributed by the members of BSSD in May 2017 and were recorded at the historical carrying value (original cost less any related accumulated depreciation) of the member as of the contribution date.

On September 12, 2018, the Company executed a $1,500,000 promissory note (see Note 7) which was used to make a capital contribution into Strive Management, LLC, a Nevada limited liability company (“Strive Management”). In exchange for the contribution, the Company received a 20% membership interest in Strive Management. The remaining interests are held by three individuals one of which is the Company’s current Chief Executive Officer. Through a management agreement with Strive Wellness of Nevada, LLC, a related party (the Company CEO is a member of this LLC), Strive Management will facilitate the cultivation, processing and distribution of marijuana in Nevada. Strive Wellness of Nevada, LLC has been allocated cultivation, processing and distribution licenses from the State of Nevada. Additionally, the Company will acquire an additional 31% ownership of Strive Management upon the approval from the State of Nevada to operate the cultivation and processing facility.

Unaudited Interim Financial StatementsPrinciples of Consolidation

Item 9 Labs consolidates all variable interest entities (“VIEs”) in which the Company is deemed to be the primary beneficiary and all other entities in which it has a controlling voting interest.  An entity is generally a VIE if it meets any of the following criteria: (i) the entity has insufficient equity to finance its activities without additional subordinated financial support from other parties, (ii) the equity investors cannot make significant decisions about the entity’s operations or (iii) the voting rights of some investors are not proportional to their obligations to absorb the expected losses of the entity or receive the expected returns of the entity and substantially all of the entity’s activities involve or are conducted on behalf of the investor with disproportionately few voting rights. The Company periodically makes judgments in determining whether its investees are VIEs and, each reporting period, the Company assesses whether it is the primary beneficiary of any of its VIEs. As of June 30, 2019 and September 30, 2018, the Company is deemed the primary beneficiary of Strive Management because the entity has insufficient equity to finance its activities without additional subordinated support. The interests in Strive Management held by non-controlling members has been presented on the statement of operations and statement of stockholders’ equity as non-controlling interest.

The consolidated financial statements include the accounts of the Company, its wholly-owned subsidiaries and variable interest entities in which the Company is the primary beneficiary. Intercompany balances and transactions have been eliminated.

The accompanying interim unaudited condensed consolidated financial statements of the Company as of June 30, 20162019,do not include all the information and 2015,notes necessary for a comprehensive presentation of financial position and results of operations and should be read in conjunction with our September 30, 2018 audited financial statements filed with the Securities and Exchange Commission on our Form 10-12G filed June 27, 2019. It is management’s opinion that all material adjustments (consisting of normal recurring adjustments) have been made, which are necessary for a fair financial statement presentation. The results for the periods then ended, are prepared in accordance with the instructions to Form 10-Q. Accordingly, the accompanying condensed consolidated financial statements and notes thereto do not reflect all disclosures required under accounting principles generally accepted in the United States (U.S. “GAAP”). However, in the opinion of management, the interim financial statements include all adjustments, consisting of only normal recurring adjustments, necessary to present fairly the Company’s financial position as of June 30, 2016 and the results of its operations and its cash flows for the periods ended June 30, 2016 and 2015. These resultsperiod are not necessarily indicative of the results to be expected for the fiscal year endedending September 30, 2016.2019.

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of Airware Labs Corp and its wholly owned subsidiary, Airware Holdings, Inc. Intercompany balances and transactions have been eliminated.

Accounting Estimates

The preparation of financial statements in conformity with accounting principles generally acceptedGenerally Accepted Accounting Principles (“GAAP”) in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could materially differ from those estimates. Significant estimates of the Company include accounting for depreciationestimated useful lives of property and amortization,equipment, deferred income taxes, accruals and contingencies, inventory reserves, estimates for customer returns,fair value of acquired intangible assets, the fair value of common stock provided as consideration and the estimated fair value of stock options and warrants.

Discontinued Operations

The Company sold the former Airware business of nasal dilator sales on May 3, 2018, see Note 4. The operating results related to this business have been classified as discontinued operations in the condensed interim consolidated financial statements in accordance with Accounting Standards Codification 205-20,Discontinued Operationsfor the three and nine months ended June 30, 2018. Accounts payable from these discontinued operations in the amount of $427,389 remain on the balance sheet as of June 30, 2019. The amount presented as other income during the three and nine months ended June 30, 2019 represents a gain resulting from the repayment of a liability acquired from Airwares that was negotiated and repaid in full at an amount less than the carrying amount.

Cash and Cash Equivalents

The Company considersCash represents cash on hand, demand deposits placed with banks and other financial institutions and all highly liquid instruments purchased with a remaining maturity of three months or less as of the purchase date of such investments. The Company maintains cash on deposit, which, can exceed federally insured limits. The Company has not experienced any losses on such accounts nor believes it is exposed to be cash equivalents.any significant credit risk on cash.

Inventory

Inventory is mostly held by a third party, consists of finished goodsAccounts Receivable and is statedNotes Receivable

Accounts receivable are reported at the loweramount management expects to collect from outstanding balances. Differences between the amount due and the amount management expects to collect are reported in the results of operations of the year in which those differences are determined, with an offsetting entry to a valuation allowance for accounts receivable. Management believes all accounts receivable outstanding as of the balance sheet dates are fully collectible, and as such has elected to not record a valuation allowance for these periods.

Deferred Costs

Deferred costs consist of the costs directly related to the production and cultivation of marijuana crops. Deferred costs are relieved to cost determined by the first-in, first-out method, or market. During the three months ended June 30, 2016, the Company established a reserve of $20,000 for inventory which will likely expire before weservices as products are abledelivered to sell it.dispensaries.

Property and Equipment

Property and equipment are recorded at cost. Depreciation is provided for on the straight-line method, over the estimated useful lives of the assets. Maintenance and repairs that neither materially add to the value of the property nor appreciably prolong its life are charged to expense as incurred. Betterments or renewals are capitalized when incurred. Gains and losses on the disposition of property and equipment are recorded in the period incurred. Production molds owned by the Company are capitalized and are included in manufacturing equipment. Pre-production design and development costs are expensed as incurred.

The estimated useful lives of property and equipment are:

Intangible Assets Subject to Amortization

Revenue Recognition

The Company recognizes revenueIntangible assets include trade name, customer relationships, website, a noncompete agreement and intellectual property obtained through a business acquisition (see Note 2). Intangible assets acquired in a business combination are recognized at fair value using generally accepted valuation methods deemed appropriate for the type of intangible asset acquired. Intangible assets with finite lives are amortized over their estimated useful life and reported net of accumulated amortization, separately from goodwill. Amortization is calculation on the sale of products at the time of delivery and acceptance. Delivery is generally FOB destination. At the time of delivery,straight-line basis using the following have occurred:estimated useful lives:

the discounted cash flow method for valuing website and intellectual property.

Revenues are recorded net of returns and co-operative advertising costs.Goodwill

Goodwill represents the excess of the purchase price paid for the acquisition of a business over the fair value of the net tangible and intangible assets acquired. Goodwill is not subject to amortization and is tested annually for impairment, or more frequently if events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable.

Income Taxes

The Company accounts for income taxes under FASB ASC 740, Income Taxes. Deferred income tax assets and liabilities are determined based upon differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.

The Company files income tax returns in the U.S. federal jurisdiction, and the State of Arizona. The Company is subject to U.S. federal, state, and local income tax examinations by tax authorities. All periods beginning on or after January 1, 2014 are open to examination by taxing authorities. The Company believes it has no tax positions for which the ultimate deductibility is highly uncertain.

Revenue Recognition

On October 1, 2017, the Company adopted ASC Topic 606, “Revenue from Contracts with Customers” (“ASC 606”) and all the related amendments. The Company elected to adopt this guidance using the modified retrospective method. The adoption of this guidance did not have a material effect on the Company’s financial position, results of operations or cash flows.

The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under U.S. GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation.

The majority of the Company’s revenue is associated with a customer contract that represents an obligation to perform services that are delivered at a single point in time.  Any costs incurred prior to the period in which the services are performed to completion are deferred and recognized as cost of services in the period in which the performance obligations are completed. Since the Company’s revenue is generated from one customer contract, the Company does not have material contract assets or liabilities that fall under ASC 606. As of June 30, 2019 and 2018, 90% of the Company’s revenues were generated for performance obligations completed in the State of Arizona.

The Company recognizes revenue as services are rendered. Services are considered complete upon successful delivery of the product to the dispensary as the Company has no further performance obligations at this point in time and collection is assured. Per the dispensary contract, the Company is paid 85% of the wholesale market price of the marijuana for the services rendered.

The Company’s revenues accounted for under ASC 606, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The sales price is generally fixed at the point of sale and all consideration from the contract is included in the transaction price. The Company’s contracts do not include multiple performance obligations or variable consideration.

Fair Value of Financial Instruments

The carrying value of the Company’s financial instruments, consisting of cash, accounts receivable, accounts payable, and accrued expenses approximate fair value due to their short term to maturity.  The Company’s long-term receivable resulting from the sale of Airware was discounted to its estimated fair value on the date (see Note 4).

Net Loss perPer Share

Basic earnings per share does not include dilution and is computed by dividing incomeloss available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflectreflects the potential dilution of securities that could share in the earnings of an entity. Dilutive securities are not included in the weighted average number of shares when inclusion would be anti-dilutive. DueAt June 30, 2019, there were 646,008 shares underlying convertible notes payable, warrants and options.

Stock-Based Compensation

The Company accounts for its stock-based awards in accordance with ASC Subtopic 718-10,“Compensation – Stock Compensation”,which requires fair value measurement on the grant date and recognition of compensation expense for all stock-based payment awards made to employees and directors. For stock options, the Company estimates the fair value using a closed option valuation (Black-Scholes) model. The fair value is then expensed over the requisite service periods of the award which is generally the vesting period and the related amount is recognized in the consolidated statements of operations. The Company recognizes forfeitures at the time they occur.

The Black-Scholes option-pricing model requires the input of certain assumptions that require the Company’s judgment, including the expected term and the expected stock price volatility of the underlying stock. The assumptions used in calculating the fair value of stock-based compensation represent management’s best estimates, but these estimates involve inherent uncertainties and the application of judgment. As a result, if factors change resulting in the use of different assumptions, stock-based compensation expense could be materially different in the future.

Reclassifications

Certain accounts and financial statement captions in the prior periods have been reclassified to conform to the current period financial statements.

Note 2 –Acquisition

On November 26, 2018, the company’s wholly owned subsidiary AZ DP Holdings, LLC (AZDP) performed an acquisition of the majority of the assets of Arizona DP Consulting, LLC (AZDPC), a consulting firm specializing in obtaining marijuana dispensary permits and cannabis related business plans. The purchase price was $1,500,000 in cash and 3,000,000 shares of restricted common stock having an aggregate value of $7,500,000 or $2.50 per share based on current market price of the Company shares at time asset purchase agreement was executed. Pursuant to the agreement, Sara Gullickson transitioned from President to CEO under a 3 year employment agreement and became a member of the board of directors of the company. Additionally, AZDP agreed to hire the employees of AZDPC and lease its existing office space which requires $3,200 of monthly rent through May 2019. This acquisition effectively terminates the contract dated June 26, 2018 described in Note 11. Below is a summary of AZDPC’s revenue, expense and net lossesincome for January 1, 2018 through August 31, 2018, and January 1, 2017 through December 31, 2017. Assets and liabilities of AZDPC were negligible so presentation was not deemed necessary.

In accordance with ASC 805,Business Combinations, the Company accounted for the acquisition of AZDP using the acquisition method of accounting. The purchase price was allocated to specific identifiable intangible assets at their respective fair values at the date of acquisition. There were no tangible assets acquired.

A summary of assets acquired in the acquisition and their fair values are presented below:

Identifiable intangible assets consist of the following as of June 30, 2019:

Future amortization of the identifiable intangible assets is as follows:

Amortization expense for the three- and nine-month periods ended June 30, 20162019 was $82,500 and 2015, basic and diluted loss per common share were$236,833, respectively. The Company had no amortizable intangible assets during the same, as the effect of potentially dilutive securities would have been anti-dilutive.nine months ended June 30, 2018.

The goodwill arising from the acquisition consists largely of synergies and economies of scale expected from combining the operations and personnel of the businesses. These synergies include access into new markets.

Note 3 - Property and Equipment, Net

The following represents a summary of our property and equipment as of June 30, 2019 and September 30, 2018:

The construction in progress relates to cultivation facilities being built in Arizona and Nevada which were not yet complete or in use as of June 30, 2019; therefore, we have not yet began to depreciate the costs of constructing these facilities.

Depreciation expense for the nine months ended June 30, 2019 and 2018 was $39,122 and $36,825, respectively, and for the three months ended June 30, 2019 and 2018 was $13,200 and $12,355, respectively.

Note 4 – Sale of Airware Assets and Investment in Health Defense LLC

On May 3, 2018, the Company entered into an intellectual property sales agreement with Health Defense LLC. Pursuant to the terms of the agreement, the Company sold all of the assets related to the former business of the Company, nasal dilator sales.

In consideration for entering into the agreement, the Company received: (i) $300,000 in cash at execution, (ii) $700,000 in cash within one year of execution and (iii) an additional $300,000 by December 31, 2019. Due to the long-term nature of the final $300,000, the Company recognized a discount of $70,070 using a discount rate of 21.50%. During the nine months ended June 30, 2019, the Company recognized $39,057 of interest income related to the accretion of this discount which is included in interest income on the accompanying consolidated statements of operations. As of June 30, 2016, there were total shares2019, the receivable was in default, though management believes it to be fully collectible within one year of 54,139,483 issuable upon conversionthese consolidated financial statements. As of June 30, 2019, unamortized discount on this long-term receivable was $11,855. As of September 30, 2018, unamortized discount on this long-term receivable was $50,912. As additional consideration, the Company was also given a 10% ownership interest in Health Defense LLC. This ownership is valued at $100,000 and is reflected on the balance sheet as an other long-term asset.

Note 5 – Notes Receivable

On May 11, 2018, the Company entered into a Promissory Note Agreement with borrower in principal amount of $150,000. This is a one year note with 20% non-compounded annual interest payable at maturity. It is convertible at the discretion of the Company into a unit offering of the borrower at a 15% discount. The note is personally guaranteed by the borrower.

On May 15, 2018, the Company entered into a Promissory Note Agreement with borrower in principal amount of $60,000. This is a one year note with 15% non-compounded annual interest payable at maturity. It is convertible at the discretion of the Company into an interest in a strategic partnership of ownership and operations of a certain dispensary license. The note is personally guaranteed by the borrower.

For the nine months ended June 30, 2019 and year ended September 30, 2018, the Company has accrued $48,712 and $15,074, respectively, of interest receivable related to these notes payable and the exercise of warrants and options that were notwhich is included in notes and interest receivables on the earnings per share calculation as they were anti-dilutive.

2.Going Concern

The Company has incurred losses since inception and requires additional funds for future operating activities. The Company’s selling activity has not reached a levelaccompanying consolidated balance. As of revenue sufficientthe date of the condensed financial statements, the notes receivable are in default though management believes them to fund its operating activities. These factors create an uncertainty as to how the Company will fund its operations and maintain sufficient cash flow to operate as a going concern. The combination of these factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern.

The Company’s ability to meet its cash requirementsbe fully collectible in the next year is dependent upon obtaining additional financing and achieving improved sales levels. If this is not achieved,twelve months.

Note 6 – Unsecured Convertible Note Payable

In the reverse recapitalization disclosed in Note 1, the Company may be unable to obtain sufficient cash flow to fund its operations and obligations, and as a result there is substantial doubt the Company will be able to continue as a going concern. The accompanying condensed consolidated financial statements have been prepared on a going concern basis, and accordingly, do not include any adjustments relating to the recoverability and classification of recorded asset amounts; nor do they include adjustments to the amounts and classification of liabilities that might be necessary should the Company be unable to continue operations or be required to sell its assets.

3. Convertible Note Payable

The Company has aassumed one unsecured convertible note payable with a principal balance of $5,000,totaling $20,000 which was due onin August 22, 2012, is unsecured, carriescarry an interest rate of 8% and is convertible to common stock at $.50 per share. As of June 30, 2019 and September 30, 2018, this unsecured convertible note payable is considered in default and has been presented as a current liability on the condensed interim consolidated balance sheets.

4. Note Payable to Former Officer

The Company has a note payable with an original principal balance of $47,500 due to a former officer, which was due on August 1, 2016, isunsecured and carries an interest rate of 0.27%. On December 5, 2013 the Company revised the terms of the Note calling for four equal payments to begin on November 1, 2015 and ending August 1, 2016. As part of this revision, the interest rate was reduced from 2% to 0.27%. The Company defaulted on the final payment due, see note 10. The following represents future minimum payments due on the outstanding balance:

5. Convertible Notes Payable to Related PartiesNote 7 – Long Term Debt

Convertible notes payable to related parties consist of the following:

On January 22, 2016,September 13, 2018, the Company entered into an Allongea Loan and Revenue Participation Agreement with Viridis Group I9 Capital LLC (“Viridis”) in which Viridis has agreed to loan the Company up to $2.7 million for the expansion of the Company’s Arizona and Nevada properties (see Note 10). As of September 30, 2018, the Company received $1,500,000 of proceeds from Viridis in the form of a promissory note. The $1,500,000 proceeds were utilized to acquire a 20% ownership in Strive Management, LLC as described in Notes 1 and 8. In exchange for the loan, Viridis will be repaid in the form of waterfall revenue participation schedules. Viridis shall receive 5% of the Company’s gross revenues from the Nevada operations, until the loan is repaid, 2% until repaid 200% of the amount loaned, and 1% of gross revenues in perpetuity or until a change in control. Payments on the loan will commence 90 days after the Nevada operation begins earning revenue. Parties acknowledge that the Company is expected to own only 51% of the Nevada operations and therefore Viridis’ revenue participation is limited to the convertible note heldCompany’s interest. The operations in Nevada have not yet begun as of the date of this filing.

The additional $1,200,000 proceeds were utilized to construct an additional 10,000 square foot cultivation and processing facility in Arizona that became operational in June 2019. The proceeds were received as construction draws between November 2018 and January 2019. In exchange for the loan, Viridis will be repaid in the form of waterfall revenue participation schedules. Viridis shall receive 5% of the Company’s gross revenues from the Arizona operations, until the loan is repaid, 2% until repaid 200% of the amount loaned, and 1% of gross revenues in perpetuity or until a change in control. Payments on the loan will commence 90 days after the Arizona operation begins earning revenue. Interest on the notes accrue monthly at a 2.9% annual rate. Interest of $24,097 has been accrued as of June 30, 2019.

Note 8 – Variable Interest Entity

As of June 30, 2019, the Company has determined that it holds a variable interest in Strive Management due to the Company being its sole source of capital. Further, the Company has agreed to construct an operational facility in Nevada. As such, Item 9 Labs Corp will raise funds as necessary ($4,000,000 expected) to construct the facility, which will be wholly owned by oura subsidiary of Item 9 Labs Corp and leased to Strive Management, LLC, the operating company. No funds have been raised as of the date of these financial statements. If the funds are not raised, the additional 31% interest due to the Company upon operational approval from the State of Nevada as discussed in Note 1 would be subject to reclamation by the other members of Strive Management. The Company has been determined to be the primary debt holder by which our linebeneficiary of credit was increased by $200,000Strive Management has the Company has the power to direct the activities that significantly impact Strive Management’s economic performance and the conversion priceobligation to absorb losses. Strive Managements financial statements as of June 30, 2019 and September 30, 2018 have been consolidated with the outstanding principal balanceCompany. Upon consolidation, the asset of Strive Management was adjusted to $.08 from $.10. In accordance with ASC 470-50,recorded at its carrying amounts. As of June 30, 2019, and September 30, 2018 the Company evaluated the modificationeffects of the debt under the terms of the newest allonge and determined the revised termsconsolidating Strive Management resulted in an extinguishmentincrease in assets of debt.  Accordingly,$626,067 and $1,500,000, respectively, primarily from cash. For the difference between the reacquisition pricethree and nine months ended June 30, 2019, Strive Management incurred income of the debt$8,508 and the net carrying amounta loss of the extinguished debt was recognized in current income.  A loss in the amount of $1,122,100 was recorded on the debt extinguishment.$66,732, respectively.

6. Related Party TransactionsNote 9 - Concentrations

As detailed in Notes 4For the three and 5, the Company has a note payable to its former President, a convertible note payable to a former advisory board member and another convertible note with an entity that owns a majority of our outstanding shares. The Company repaid $35,625 of the note payable to former officer during the nine months ended June 30, 2016.2019 and 2018, 92% and 100%, respectively, of the Company’s revenue was generated from a single customer. All trade accounts receivable at June 30, 2019 and 2018 was due from one customer.

Note 10 - Commitments and Contingencies

The production and possession of marijuana is prohibited by the United States of America, though the state of Arizona allows these activities to be performed at licensed facilities such as BSSD. The Company does not believe the federal prohibition of these activities will negatively impact the business. As such, the Company has not elected to record a related accrual contingency.

The Company is in default on convertible notes payable totaling $20,000 (see Note 6). The Company has attempted to communicate with the note holder to request extension or conversion, but has been unsuccessful in doing so. The full balance on this note is included in current liabilities.

On April 20, 2018, the Company entered into an agreement for the purchase of approximately 44 acres of land from an affiliate of a founding member of BSSD. The purchase price of the property is $3,000,000, payable as follows; (i) $200,000 deposited with escrow agent as an initial earnest money deposit in April 2018, (ii) on or before February 1, 2019, the Company will deposit an additional $800,000 into escrow as additional earnest money deposit and (iii) the balance of the purchase price shall be paid via a promissory note. The earnest money amounts are non-refundable. The Company has negotiated an amendment to this agreement that will spread the $800,000 payment over the course of 4 months through June 30, 2019. As of June 30, 2019, the Company had paid a total of $600,000 which was deposited in escrow, and classified as a long-term asset on the consolidated balance sheet as of June 30, 2019. As of the date of these financial statements, a total of $600,000 has been deposited in escrow.

On June 26, 2018, the Company entered into a contractor agreement with Chase Herschman pursuant to which he will provide services in exchange for $120,000 annually, payable each month; up to $420,000 in common stock options which shall vest upon the occurrence of certain benchmarks as described in the contractor agreement and a commission of 1% of the gross profits of the Company. The term of the agreement is a period of three years.

Under the terms of the Loan and Revenue Participation Agreement (see Note 7), upon a change in control of the Company, Viridis will be entitled to receive 200% of the principal amount of the loans to the Company computed after considering previous revenue participation payments through the date of change of control and 1% of the aggregate sales price or consideration received in the change in control transaction.

As of September 30, 2018, the Company received the $1,500,000 and invested the funds in Strive Management (see Notes 7 and 8). The remaining $1,200,000 has been provided by Viridis directly to contractors of the Arizona property from an account owned and controlled by Viridis. The Company recorded the $1,200,000 as construction in progress (see Note 3) a long-term debt (see Note 7) upon the completion and occupancy of the Arizona facility expansion, as agreed upon in the terms of the note which occurred in June 2019.

As part of the agreement to invest in Strive Management, the Company has committed to raise funding of approximately $4,000,000 to complete the construction of a cultivation and processing facility in Nevada which will be leased to Strive Management LLC.

On October 22, 2018 the Company entered into a 6 month services agreement with Axiom Group to provide marketing and data distribution services. As part of the agreement, the Company will pay a sum of $15,000 and issue 15,000 shares of common stock to Axiom Group each month the agreement is in place. This contract was terminated in December 2018.

On March 11, 2019 the Company entered into a 6 month services agreement with JLS Ventures to provide marketing and data distribution services. As part of the agreement, the Company will pay a sum of $15,000 and issue 35,000 shares of common stock to JLS Ventures each month the agreement is in place. This contract was terminated in May 2019.

The Company made a commitment to its Chief Operating Officer to issue 9,615 common stock shares quarterly, starting January 2019, as compensation through October 2019. The shares are being valued at $2.60 per share as that was the market closing price as of the date the agreement was signed. The Company recognized $25,000 of stock compensation for the shares issued in April 2019 which is included in payroll and employee related expenses on the statements of operations.

Note 11 – Related Party Transactions

As discussed in Note 1, on March 20, 2018, the Company issued 40,355,771 shares of common stock to the members of BSSD for their membership interests.

As discussed in Note 10, the Company has entered into an agreement as of April 20, 2018 for the purchase of land. The land owner is one of the original members of BSSD and a current employee of the Company.

As discussed in Notes 7 and 10, the Company has entered into a Loan and Revenue Participation Agreement and Promissory Note with Viridis. The member of Viridis was elected to the Company’s board of directors on December 21, 2018.

As discussed in theDescription of the Business section of Note 1 and in Note 2 of the financial statement disclosures, the Company is involved in transactions with companies that are owned in whole, or in part by the Company’s CEO, Sara Gullickson.

Note 12 - Stockholders’ Deficit

Common Stock

As discussed in Note 1, on March 20, 2018, the Company issued 40,355,771 shares of common stock to the members of BSSD for their membership interests.

During the nine months ended June 30, 2016,2019, the Company recorded $59,055 in expenseraised $5,660,003 via private placements. The selling price for fees due to5,000,000 shares was $1 per share and the selling price for 440,000 was $1.50 per share for a company owned by its CFO for her services as CFO. Of this amount¸ $44,472 has been paid.

During the nine months ended June 30, 2016, the Company recorded $93,744 in expense for fees due to a company owned by its President for his services as President. Of this amount, $52,080 has been paid.

During the nine months ended June 30, 2016, the Company paid zero cash for interest on the related party debt.

7. Commitments and Contingencies

On December 22, 2011, the Company entered into a distribution agreement that provides for the issuancetotal of 5,440,002 shares of common stock issued. Additionally, 158,529 shares with a market value of $270,000 were issued to contractors for services and 42,759 shares valued at $150,000 were issued to employees as compensation

Warrants

As of June 30, 2019 there are 298,411 warrants with an expiration date of 3 years, for the purchase of the Company’s common stock in an amount equal to 15% of the total products purchased by the distributor from the Company at the invoice price against the previous year’s purchases of paid invoices.outstanding. The warrant price will be equal to the closing price of Airware Labs Corp.’s stock price at the anniversary date of the agreement. During the nine months ended June 30, 2016, the Company issued a warrant to purchase 252,124 shares of common stock at $.08 per share to this distributor.

On January 6, 2014, the Company entered into a license agreement with Eastar Industries, Co. (“Eastar”), pursuant to which the Company granted Eastar an exclusive license to sell its products in China for a term of five years in exchange for a royalty equal to 18% of gross profits generated by the sales of products in China. Additionally, the Company and Eastar agreed to establish a joint venture company in Hong Kong or Shanghai which will be assigned Eastar’s rights under the agreement and of which 18% of the joint venture will be owned by the Company. As of June 30, 2016, the joint venture has yet to be established.

The Company entered into an office lease agreement commencing June 1, 2014 and expiring August 31, 2017. As part of the lease agreement, a concession of the first three months’ rent was provided. Total rent to be paid over the course of the lease is being expensed ratably over the period of the entire lease, creating a deferred rent liability of $3,065 as of June 30, 2016.

On August 17, 2015, the Company entered into an agreement with a company owned by its President for his services as President on a contract basis in exchange for a fixed monthly fee. A total of $93,744 was recorded as expenseno new warrants during the nine months ended June 30, 2016 per this agreement, of which $52,080 has been paid.2019 and no warrants expired during that period. Warrants outstanding are as follows:

The Company sells the majority of its products through major distributors. The Company warrants to the distributors that the product will be free from defects in material and workmanship. The Company has determined its product warranty to be immaterial at June 30, 2016. The likelihood that the Company’s estimate of the accrued product warranty claims will materially change in the near term is considered remote.

8. Stockholders’ Deficit(1) As discussed in Note 2, on March 20, 2018 the Company executed an agreement to acquire all the voting interest in BSSD Group, LLC. As BSSD Group, LLC is the accounting acquirer, all previously outstanding warrants were re-issued under the new company.

Common Stock Options

During the nine months ended June 30, 2016, the Company issued 4,534,887 shares of common stock in payment of September 2015 through March 2016 interest totaling $226,724 on the primary debt holders convertible note.

On December 31, 2015, the Company issued 200,000 shares of common stock per subscription agreements totaling $20,000. The Company received net proceeds of $18,000, net of issuance costs of $2,000 paid as a capital marketing fee. As part of these stock subscriptions, 100,000 warrants to purchase common stock at $.25 were also issued.

On December 31, 2015, the Company issued 96,071 shares of common stock for the payment of consulting services rendered to the Company between April 1, 2015 and September 30, 2015. The shares were valued at the average trading price over the period of service, which approximated fair value, in the amount of $12,750.

During the quarter ended December 31, 2015, the company received $45,500 towards the purchase of 227,500 shares of common stock. Net proceeds amounted to $36,400 after the issuance costs of $9,100 paid as a capital marketing fee. This was part of a subscription agreement totaling $375,000. These shares, as well as others paid for per the same subscription agreement totaling 517,500, were issued on March 15, 2016.

On March 15, 2016, the Company issued 100,000 shares of common stock per a subscription agreement for $10,000. The Company received net proceeds of $9,000, net of issuance costs of $1,000 paid as a capital marketing fee. As part of this stock subscription, 50,000 warrants to purchase common stock at $.25 were also issued.

On April 7, 2016, the Company issued 75,917 shares of common stock for the payment of services rendered to the Company between October 1, 2015 and February 29, 2016. The shares were valued at the closing price on the various vendor invoice dates, in the amount of $18,485.

Warrants

The balance of warrants outstanding for purchase of the Company’s common stock as of June 30, 2016 is as follows:

(1) During the nine months ended June 30, 2016, the company issued stock purchase warrants as part of stock subscription agreements.

(2) On December 22, 2015, the Company issued a three-year warrant at $.08 to purchase 252,124 shares of common stock per a distribution agreement.

Stock Options

The Company had the following options outstanding at June 30, 2016:

(1) On October 15, 2015, the Company entered into an agreement with a patent attorney to provide intellectual property services as in-house patent counsel. Per the agreement, he received monthly stock option grants. He was to receive $7,500 per month in stock option grants, and the quantity of stock options issued monthly was determined by the closing price on the last day of the month. These services were suspended as of February 29, 2016.

(2) On MarchMay 8, 2016,2018, the Company granted a total of 583,333 stock options for the purchase of the Company’s common stock. Included in this amount, 433,333 stock options were granted to corporate officers and 150,00022,500 stock options to a Board member.board members. The options are exercisable at $.15$2.40 per share of common stock overwith a ten year term. The options for the Board member vested immediately, all otherswill vest equally over three years unless there is a change of control of the next three years.

During the three and nine month periods ended June 30, 2016, $8,524 and $54,481, respectively, was expensed for the pro-rata vesting of stock-based compensation.Company at which time any unvested options vest immediately. As of June 30, 2016,2019, there are 294,991 stock options outstanding.

As discussed in Note 2, on March 20, 2018 the balance of unrecognized compensation cost relatedCompany executed an agreement to non-vested stock-based compensation to be expensedacquire all the voting interest in future periodsBSSD Group, LLC. As BSSD Group, LLC is the accounting acquirer, all previously outstanding options were re-issued and vested immediately as this was $65,461.considered a change in control.

The Company determines the fair value of stock options issued on the date of grant using the Black-Scholes option-pricing model. There was no option activity in the nine months ended June 30, 2019. The following assumptions were used for determining the fair value of the options granted during the nine monthsyear ended JuneSeptember 30, 2016:2018:

9. Significant CustomerWe do not have an extensive history as a public company and our common stock transactions are too infrequent, therefore we could not practicably estimate the expected volatility of our own stock. Accordingly, we have substituted the historical volatility of a relevant comparable company that is publicly traded and does business within the industry we operate.

The Company generally sells throughoptions granted during the year ended September 30, 2018 were determined to have a limited numberfair value at date of large distributors.grant of $2.40. The Company invoicesunrecognized compensation expense of $13,856 will be recognized over a weighted average period of 1.09 years. Compensation expense in the distributors directly as opposed to the ultimate retail store. Consequently, the Company’s sales are to a small numberamount of customers. For both$3,178 and $9,534, respectively, was recognized in the three and nine months ended June 30, 2016, sales to two distributors was approximately 92% of our total sales.2019.

10.There was no activity in stock options during the nine months ended June 30, 2019 and 2018. 294,991 and 272,491 options remain outstanding as of June 30, 2019 and 2018, respectively. 272,491 options were exercisable as of June 30, 2019 and 2018.

Note 13 - Subsequent Events

On July 28, 2016,1, 2019, the Company entered into an Allongea 3 year agreement with a concert venue to be the convertible note held by our primary debt holder by which our line of credit was increased by $100,000. The Company issued a warrant to purchase 2,000,000 shares of common stock at $.05 according toname sponsor for the terms of this Allonge.

As of August 1, 2016, the Company defaulted on the final $11,875 payment payable on the loan to a former officer.

On August 16, 2016,venue. In exchange, the Company issued 2,740,49445,457 shares of restricted common stock valued at $200,000($4.40/share) and is to our primary debt holder as payment for interest on loans to the Company for April through July 2016. The Company also issued 104,258 shares of common stockpay $5,000 monthly for the payment of consulting services rendered to the Company between October 1, 2015first 12 months and June 30, 2016. The shares were valued at the average trading price over the period of service, which approximated fair value,$60,000 in the amount of $13,500.July 2020 and 2021.

End of Notes to Financial StatementsOn July 3, 2019, the Company’s Board approved an employment agreement for a sales director. In connection therewith, the Company granted 16,667 common stock shares totaling $50,000 which will vest six months from the employment agreement.

The following Management's Discussion and Analysis should be read in conjunction with AirwareItem 9 Labs Corp.’s financial statements and the related notes thereto. The Management's Discussion and Analysis contains forward-looking statements that involve risks and uncertainties, such as statements of our plans, objectives, expectations and intentions. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect,” and the like, and/or future-tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements in this Report on Form 10-Q. The Company’s actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of several factors. The Company does not undertake any obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this Report on Form 10-Q.

The following discussion should be read in conjunction with our unaudited consolidated financial statements and related notes and other financial data included elsewhere in this report. See also the notes to our consolidated financial statements and Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report onRegistration Statement Form 10-K10-12G including audit for the year ended September 30, 2015.2018, filed with the Commission on June 27, 2019

Overview

Item 9 Labs produces premium cannabis and cannabis related products in a rapidly growing market. We currently offer more than 300 products that we group in the following categories: flower; concentrates; distillates; and hardware. Our product offerings will continue to grow as we develop new products to meet the needs of the end-users. We make our products available to consumers through licensed dispensaries in Arizona. In just over a year from our first product delivery, Item 9 Labs’ products are now carried in more than 50 dispensaries throughout the state of Arizona.

We believe our past and future success is dependent upon our ongoing ability to understand the needs and desires of the consumers; and we develop and offer products that meet their needs.

The objective of Item 9 Labs is to leverage our assets (tangible and intangible) to fuel the growth of our share of the Arizona cannabis market, as well as expand the geographical reach of our products into markets outside of Arizona, with the ultimate goal of providing comfortable cannabis health solutions to a larger population in a manner that will create value for our shareholders.

We will expand into other markets through various methods, and will utilize strategic partnerships as necessary to provide the synergies to assist in our growth. As part of this expansion plan, we acquired land in Pahrump, Nevada to build our second production facility. Through partnerships, we obtained cultivation, production and distribution licenses in the state of Nevada. Additionally, we have plans to expand to an additional 6-8 markets by December 2019.

Results of Operations

Results of OperationsFor the Three Month Period Ended June 30, 2019, as Compared to the Comparable Prior Period Ended June 30, 2018

Revenue

Total revenueRevenue for the three months ended June 30, 20162019 was $64,466, as$1,542,067, an increase of $1,102,154 or 251% compared to $14,106revenue of $439,913 for the three months ended June 30, 2015. The2018. This increase in revenue is due to fulfilling a sizable order totaling $63,360 to one of our major distributors during the quarter ended June 30, 2016. Operating expenses in the quarter ended June 30, 2016 amounted to $169,607 as compared to $237,750 for the quarter ended June 30, 2015. The decrease in expenses iswas primarily due to a reductionan overall increase in marketing expenditures. The net lossmonthly sales as production and demand for our products grew. Additionally, $189,722 of the increase in revenues was attributable to the acquisition of Arizona DP Consulting, LLC in November 2018.

Cost of Services

Costs of services for the three months ended June 30, 20162019 was $405,938$697,672 and consists primarily of labor, materials, supplies and utilities. Costs of services as compared to $842,730a percentage of revenues was 45% for the quarterthree months ended June 30, 2015. This is2019 compared to the three months ended June 30, 2018 of 86% as certain costs, predominantly labor and materials, reduced per unit of production as operating efficiencies were gained.

Gross Profit

Gross profit for the three months ended June 30, 2019 was $844,395 compared to $63,200 for the three months ended June 30, 2018. Gross margin for the three months ended June 30, 2019 was 55% compared to 14% for the three months ended June 30, 2018. The increase was due to a significant decreasethe continued improvement in interest expense from debt discount.the operating capacity of the Company’s cultivation and processing facilities.

Operating Expenses

Total operating expenses for the three months ended June 30, 2019 were $1,658,253 compared to $447,878 for the three months ended June 30, 2018, an increase of $1,210,375. Operating expenses as a percentage of gross profit decreased from 709% to 196% for the periods compared. $1,160,207 of the operating expenses for the period ended June 30, 2019 were for corporate expenses, not directly related to generating revenue, but instead utilized for assembling the workforce and resources to manage the expansion plans we have in place. Management believes this ratio will decrease for current and future operations as the expectation is that revenues will grow at a much faster rate than operating expenses.

For the Nine Month Period Ended June 30, 2019, as Compared to the Comparable Prior Period Ended June 30, 2018

Revenue

Revenue for the nine months ended June 30, 20162019 was $182,297, as$3,627,951, an increase of $2,682,356 or 284% compared to $117,877revenue of $945,595 for the nine months ended June 30, 2015. Operating expenses2018. This increase was primarily due to an overall increase in monthly sales as production and demand for our products grew. Additionally, $363,656 of the nine months ended June 30, 2016 amountedincrease in revenues was attributable to $587,041 as compared to $866,080the acquisition of Arizona DP Consulting, LLC in November 2018.

Cost of Services

Costs of services for the nine months ended June 30, 2015. The decrease in expenses is2019 was $1,702,828 and consists primarily due to reductions in marketing expendituresof labor, materials, supplies and professional fees. The net lossutilities. Costs of services as a percentage of revenues was 47% for the nine months ended June 30, 2016 was $2,430,934 as2019 compared to $2,764,457the nine months ended June 30, 2018 of 73% as certain costs, predominantly labor and materials, reduced per unit of production as operating efficiencies were gained.

Gross Profit

Gross profit for the nine months ended June 30, 2015. This is2019 was $1,925,123 compared to $259,119 for the nine months ended June 30, 2018. Gross margin for the nine months ended June 30, 2019 was 53% compared to 27% for the nine months ended June 30, 2018. The increase was due to increased sales resulting from greater demand from onethe continued improvement in the operating capacity of our distributors, as well as decreased expenditures for marketingthe Company’s cultivation and professional fees.processing facilities.

Operating Expenses

Total operating expenses for the nine months ended June 30, 2019 were $3,851,183 compared to $587,278 for the nine months ended June 30, 2018, an increase of $3,263,905. Operating expenses as a percentage of gross profit decreased from 227% to 200% for the periods compared. $2,599,749 of the operating expenses for the nine months ended June 30, 2019 were for corporate expenses, not directly related to generating revenue, but instead utilized for assembling the workforce and resources to manage the expansion plans we have in place. Management believes this ratio will decrease for current and future operations as the expectation is that revenues will grow at a much faster rate than operating expenses.

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

Liquidity and Capital Resources

Our balance sheet asprimary need for liquidity is to fund working capital requirements of our business, capital expenditures, acquisitions, debt service, and for general corporate purposes. Our primary source of liquidity is funds generated by financing activities and from private placements. Our ability to fund our operations, to make planned capital expenditures, to make planned acquisitions, to make scheduled debt payments, and to repay or refinance indebtedness depends on our future operating performance and cash flows, which are subject to prevailing economic conditions and financial, business and other factors, some of which are beyond our control.

As of June 30, 2016 reflects $9,049 in2019, the Company had $786,813 of cash and working capital of $968,590 (current assets minus current liabilities), compared with $1,674,266 of cash equivalents as compared to $41,745and $2,279,334 of working capital as of September 30, 2015.To date,2018. The decrease of $1,310,744 in our working capital and $887,453 in cash was primarily due to investing in construction projects in Arizona and Nevada totaling $4,797,374, acquisition outlays of $1,500,000 and increase in deferred costs of $988,914. This was offset by stock sales totaling $5,660,003 and the issuance of long term debt of $1,200,000. The Company has incurred operating losses, has incurred negativeis an early stage growth company. It is generating cash from sales and is investing its capital reserves in current operations and new acquisitions that will generate additional earnings in the long term. The Company expects that its cash on hand and cash flows from operations, and has a working capital deficit of $2,017,861. Management is continuing to pursuealong with private and/or public financing, from various sources, including private placements from investors and institutions. Management believes these efforts will contribute toward funding the Company’s activities until sufficient revenue can be earned from future operations. In addition, the Company is seeking additional distribution partners in both domestic and foreign markets. Management believes these combined efforts, if successful, will be sufficientadequate to meet its working capital needsrequirements and its currently anticipated expenditure levelsoperational needs for the next year. At this time, our Company does not have a commitment from any broker/dealer to provide additional financing,12 months.

Cash Flows

The following table summarizes the sources and does not have sufficient working capital to support operationsuses of cash for each of the next twelve months. There is no assurance that any additional financing will be available or if available, on terms that will be acceptable.  periods presented:

Cash Flow from Operating Activities

During the nine months ended June 30, 2016, the Company’s2019, operating activities used $260,471 in$1,165,082 of cash, as compared to $544,546 used by operating activities for the nine months ended June 30, 2015. Theprimarily resulting from a net loss of $2,130,749, and a decrease in cash due to changes in operating assets and liabilities. Cash used forby changes in operating activities isassets and liabilities was primarily due to accruing, rather than paying cash for, officer salaries duringincreases of $298,562 in accounts receivable, deferred costs of $988,914 and prepaid expenses of $61,308, which was offset by the nine months ended June 30, 2016, and reductionsincrease in cash payments for marketing activities.

Cash Flow from Investing Activities

During the nine month periods ended June 30, 2016 and 2015, the Company used $0 and $6,710 respectively, in cash for investing activities. The decrease in cash used for investing activities is due to there not having been any purchasesaccrued expenses of fixed assets during the nine months ended June 30, 2016.

Cash Flow from Financing Activities$1,192,966.

During the nine months ended June 30, 2016,2018, operating activities used $344,537 of cash, primarily resulting from net loss of $288,697 and net cash used by changes in our operating assets and liabilities of $164,245. Cash used by changes in operating assets and liabilities was primarily due to an increase in deferred costs of $213,440, and an increase in accrued expenses of $20,104.

During the Company received $227,775year ended September 30, 2018, operating activities used $972,263 of cash, primarily resulting from a net loss of $604,669 and net cash used in cash from financing activities, which consistedoperating assets and liabilities of $63,400$402,870. Cash used by changes in stockoperating assets and warrants issued for cashliabilities was primarily due to an increase in accounts payable of $57,660, accrued payroll of $36,733, and $200,000 in proceeds from convertible notes payable to a related party, which wasaccrued income tax of $88,826, offset by $35,625an increase in repaymentdeferred costs of notes payable to$577,681.

During the period ended September 30, 2017, operating activities used $177,782 of cash, primarily resulting from a former officer. This compares with $544,122 in cash from financing activities duringnet loss of $181,522.

Investing Activities

During the nine months ended June 30, 2015,2019, investing activities used $6,582,374 of cash, consisting primarily of payments totaling $4,797,374 in purchases of property and equipment, $1,500,000 used in acquiring the assets of AZ DP Consulting, LLC and $400,000 in deposits made on a land acquisition offset by $115,000 in cash received on the receivable for the sale of Airware assets. During the nine months ended June 30, 2018, investing activities used $157,253 of cash, consisting primarily of $73,616 in purchases of property and equipment, $210,000 of issuances of notes receivable and $200,000 in deposits made on a land acquisition, offset by $26,363 in cash received in the merger and $300,000 in cash received in the sale of Airware assets.

During the year ended September 30, 2018, investing activities used $362,881 of cash, consisting primarily of payments totaling $340,244 in purchases of property and equipment, $200,000 in deposits made on a land acquisition, and $210,000 in extending notes receivable offset by $300,000 in cash received on the sale of Airware assets. During the period ended September 30, 2017, there was no cash investing activity.

Financing Activities

During the nine months ended June 30, 2019, financing activities provided $6,860,003, of which consisted$5,660,003 was proceeds from the sale of $68,800 incommon stock and warrants issued for$1,200,000 was proceeds from the issuance of long term debt. During the nine months ended June 30, 2018, financing activities provided $1,511,600 of cash, $498,000 in financingall of which was proceeds from notes payable, offset by $22,678 in repaymentthe sale of notes payable.common stock.

Going ConcernDuring the year ended September 30, 2018, financing activities provided $2,995,550, which included proceeds from the sale of common stock of $1,495,550 and cash proceeds from a note payable of $1,500,000. During the period ended September 30, 2017, financing activities provided $191,642 of cash, all of which was from member contributions.

Anticipated Capital Requirements

We have not attained profitable operations and are dependent upon obtaining financingestimate that our capital requirements to pursue any extensive acquisitions and activities. For these reasons, there is substantial doubt that weimplement our expansion plan over the next 18 months will be ableapproximately $15,000,000 as described in the table below. These estimates may change significantly depending on the nature of our future business activities, expansion rollout, identification of suitable acquisition targets, and our ability to continue asraise capital necessary to conduct the aforementioned activities. We further anticipate incurring additional costs and expenses for accounting, legal, and other miscellaneous fees relating to compliance with SEC requirements and the filing of the registration statement of which this prospectus forms a going concern.part.

Given that our cash needs are strongly driven by our growth requirements, we also intend to maintain a cash reserve for other risk contingencies that may arise.

Future Financings

We will continueintend to relymeet our cash requirements for the next 12 months through the use of the cash we have on hand and through business operations, future equity salesfinancing, debt financing, or other sources, which may result in further dilution in the equity ownership of our common sharesshares. We currently do not have any other arrangements in orderplace to continue to fund our business operations. Issuances of additional shares will result in dilution to existing stockholders. Therecomplete any private placement financings and there is no assurance that we will achievebe successful in completing any additional sales of the equity securities or arrange for debt or other financingsuch financings on terms that will be acceptable to fund our operations and other activities.us.